Quintiles
North America, North Carolina, United States, Durham
Description
Quintiles is a provider of biopharmaceutical development and commercial outsourcing services for drugs on the market.
Investor Profile
Quintiles has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series E, Series B rounds (top funding stages).
- Majority of deals are located in United States, Israel.
- Strong thematic focus on Biotechnology, Biopharma, Therapeutics.
Stage Focus
- Series Unknown (25%)
- Series E (25%)
- Series B (25%)
- Series D (25%)
Country Focus
- United States (75%)
- Israel (25%)
Industry Focus
- Biotechnology
- Biopharma
- Therapeutics
- Pharmaceutical
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
